Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279364
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-02-19
Brief Title:
A Study of SKB264 Versus Investigators Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
Sponsor:
Organization:
Sichuan Kelun Pharmaceutical Research Institute Co Ltd